Myoglobin Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 4.30 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Myoglobin Market Analysis
The myoglobin market is expected to grow at a registered CAGR of 4.3% during the forecast period.
The COVID-19 Pandemic had impacted the global myoglobin market. Patients with COVID-19 have high levels of myoglobin supply to cells in muscles, and myoglobin has better prognostic performance than other cardiac markers in COVID-19. Besides, myoglobin is not only an important marker of myocardial injury, but it indicates systemic muscle damage. Hence, it was largely used during COVID-19 pandemic. For instance, according to the study published in the Frontier in Cardiovascular Medicine in November 2021, individuals with severe COVID-19 exhibited higher myoglobin (mb) levels than non-COVID-19 patients. Elevated mb levels and COVID-19 were associated with a significantly increased risk of death and severe illness. Thus, myoglobin was used during pandemic which resulted in the significant market growth.
The growing prevalence of cardiovascular diseases is the major factor that is driving the growth of the market studied. For instance, as per the American College of Cardiology Foundation data published in 2022, the prevalence of valvular heart diseases (VHD) is rising in the United States, with more than 5 million Americans diagnosed each year, while up to 1.5 million people suffer from aortic stenosis (AS) in the United States. Approximately 500,000 of these patients suffer from severe AS. A timely diagnosis of heart conditions allows clinicians to analyze the risk of their patients and prescribe relevant treatment. Hence, it is likely to increase the demand for myoglobin, thereby boosting the market's growth.
According to the study published in PubMed in August 2022, myoglobin is present in skeletal and cardiac muscle tissue. Myoglobin can be found in the blood 1 hour after myocardial damage, peaks between 4 and 12 hours later, and then promptly returns to baseline levels due to its low molecular weight. Thus, given its significance in the diagnosis of myocardial infarction, the demand for myoglobin is expected to increase over the forecast period.
However, a lack of awareness about myoglobin is expected to restrain market growth over the forecast period.
Myoglobin Market Trends
Diagnostic Laboratories Segment Holds Significant Share in Myoglobin Market
Diagnostic laboratories are diagnostic centres where all different types of diagnostics are performed. Usually, they have high-quality equipment, and the results obtained from these laboratories are accurate. Diagnostic laboratories are found to be crucial to the entire healthcare system, in terms of both quality of care and financial performance. The demand for diagnostics labs is increasing as the patient population is found to be increasing and people mostly prefer to visit diagnostics labs to diagnose diseases. Additionally, these labs can process high workloads faster.
The growing burden of cardiac diseases is expected to increase demand for diagnosis of these diseases, thereby boosting segment growth. For instance, the "UK Factsheet January 2022" published by the "British Heart Foundation (BHF)" shows that around 7.6 million people are living with heart and circulatory diseases in the United Kingdom. Thus, the significant burden of heart disease is expected to lead to a rise in demand for myoglobin tests or reagents over the forecast period.
Thus, all the aforementioned factors are expected to boost segment growth over the forecast period.
North America Holds Significant Share in the Market and Expected to Grow in Forecast Period
The myoglobin market holds a significant share in the North American region due to the factors such as the well-established biotechnology industry in the United States and the growing investments in the research and development (R&D) of cardiac biomarkers. In addition, the growing burden of cardiovascular diseases in the region further propels the growth of the market. For instance, according to the National Center for Health Statistics published in May 2021, the proportion of people who have chronic cardiac diseases has increased to 4.9% in 2021 from 4.6% in 2020. As a result, the market is anticipated to grow in the region over the course of the projected period due to the rising incidence of cardiovascular diseases.
Additionally, as per the CDC report published in October 2022, every year, about 805,000 people in the United States have a heart attack. Of these, 605,000 are a first heart attack. Myoglobin is an important biomarker in the diagnosis of cardiac diseases and hence rising prevalence of cardiac diseases is expected to boost the market over the forecast period.
Hence, with the rising concerns regarding cardiovascular disorders and increasing spending on the R&D of novel biomarkers, the market is expected to grow over the forecast period.
Myoglobin Industry Overview
Myoglobin market is fragmented with the presence of several regional and global market players. Major players are focused on expanding their business in different areas by adopting various market strategies such as partnerships, collaborations, acquisitions, and mergers, etc. Key players in the market are Bio-Rad Laboratories, Inc., Merck KgaA, OriGene Technologies, Inc., Scripps Laboratories, Thermo Fisher Scientific.
Myoglobin Market Leaders
-
Bio-Rad Laboratories, Inc.
-
Merck KGaA
-
OriGene Technologies, Inc.
-
Scripps Laboratories
-
Thermo Fisher Scientific
*Disclaimer: Major Players sorted in no particular order
Myoglobin Market News
- In December 2022, Argentinian startup Ergo Bioscience has announced the use of precision fermentation to create plant-based versions of animal ingredients, such as myoglobin and casein.
- In November 2022, Ergo Bioscience & Aethera Biotech partnered to scale up animal-free ingredients. The initial focus will be on improving the biotech processes for producing animal-free myoglobin and casein.
Myoglobin Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Prevalence of Cardiovascular Diseases
- 4.2.2 Growing Funding From Public and Private Organizations for R&D
-
4.3 Market Restraints
- 4.3.1 Lack of Awareness about Myoglobin
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Product
- 5.1.1 Human Myoglobin
- 5.1.2 Animal Myoglobin
-
5.2 By End-User
- 5.2.1 Hospitals
- 5.2.2 Diagnostic Laboratories
- 5.2.3 Research and Academic Institutes
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Bio-Rad Laboratories, Inc.
- 6.1.2 BODITECH MED INC
- 6.1.3 Calzyme
- 6.1.4 Lee BioSolutions (Medix Biochemica)
- 6.1.5 Merck KGaA
- 6.1.6 OriGene Technologies, Inc.
- 6.1.7 Scripps Laboratories
- 6.1.8 Thermo Fisher Scientific
- 6.1.9 Laboratory Corporation of America Holdings
- 6.1.10 Bon Opus Biosciences, LLC.
- 6.1.11 Abnova Corporation
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityMyoglobin Industry Segmentation
As per the scope of the report, Myoglobin (Mb) is a cytoplasmic hemoprotein that binds and stores oxygen in cardiac myocytes and oxidative skeletal muscle fibers when there is insufficient delivery of blood oxygen. Myoglobin is a potential biomarker detected in the blood and serves as indices for physiological and pathological assessment in the diagnosis of various cardiological disorders. The Myoglobin Market is segmented by Product (Human Myoglobin and Animal Myoglobin), End User (Hospitals, Diagnostic Laboratories, and Research and Academic Institutes), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.
| By Product | Human Myoglobin | |
| Animal Myoglobin | ||
| By End-User | Hospitals | |
| Diagnostic Laboratories | ||
| Research and Academic Institutes | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Myoglobin Market Research FAQs
What is the current Myoglobin Market size?
The Myoglobin Market is projected to register a CAGR of 4.30% during the forecast period (2024-2029)
Who are the key players in Myoglobin Market?
Bio-Rad Laboratories, Inc., Merck KGaA, OriGene Technologies, Inc., Scripps Laboratories and Thermo Fisher Scientific are the major companies operating in the Myoglobin Market.
Which is the fastest growing region in Myoglobin Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Myoglobin Market?
In 2024, the North America accounts for the largest market share in Myoglobin Market.
What years does this Myoglobin Market cover?
The report covers the Myoglobin Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Myoglobin Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Myoglobin Industry Report
Statistics for the 2024 Myoglobin market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Myoglobin analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
